Suggestions
Benjamin Oakes
CEO I Scribe Therapeutics
Benjamin L. Oakes is a leading figure in the field of molecular and genetic engineering, specializing in the creation of advanced CRISPR therapeutics. With a strong educational background and a wealth of experience in esteemed organizations, he has established himself as an authority in this cutting-edge domain.
Benjamin pursued his Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology from the University of California, Berkeley, where he honed his expertise in the intricate workings of biological systems at the molecular level. Prior to this, he completed his Bachelor of Arts in Philosophy and Biology-Neuroscience at Colby College, where he laid the foundations for his future pursuits in research and innovation. His academic journey commenced at The Pingry School, providing him with a solid footing for his future scholarly endeavors.
Throughout his career, Benjamin has held significant roles in various prestigious organizations, showcasing his versatile skill set and deep understanding of genetic and molecular concepts. He served as the Chief Executive Officer at Scribe Therapeutics, where he spearheaded the development of groundbreaking technologies in the realm of genetic engineering. Additionally, he contributed extensively as a Principal Investigator and Fellow at the Innovative Genomics Institute, further solidifying his reputation as a trailblazer in the field. Benjamin also made notable contributions during his tenure as a PhD Candidate in Molecular & Cell Biology at UC Berkeley, working within the esteemed Savage lab & Doudna Lab. Prior to that, he excelled as a Research Specialist at the Lewis-Sigler Institute for Integrative Genomics at Princeton University, where his research acumen shone brightly.
Early in his career, Benjamin engaged in valuable research experiences that laid the groundwork for his future successes. His role as a Research Intern at Rinat Neuroscience, a division of Pfizer, provided him with hands-on experience in a corporate research setting. He also delved into independent research at the Fekete Lab at Colby College, showcasing his early passion for scientific inquiry and innovation.
Benjamin L. Oakes's unwavering commitment to advancing the frontiers of molecular and genetic engineering, coupled with his extensive academic journey and diverse research experiences, position him as a luminary in the field. His achievements and contributions underscore his dedication to pushing the boundaries of scientific discovery and driving innovations that have the potential to revolutionize the field of CRISPR therapeutics.
